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ABSTRACT 
Lack of knowledge and clinical experience in the event of an emergency are a lethal 
combination. Adrenaline is the drug of choice for resuscitation during cardiovascular 
collapse. Incorrectly dosing patients with adrenaline can lead to death by overdose or by 
undertreating the emergent condition. This highlights the importance, not only of 
resuscitation protocols but also the physician’s knowledge of and adherence to such 
guidelines. Research has consistently shown that physicians commonly make dosing 
mistakes during emergencies concerning adrenaline. Identifying whether or not this is due 
to a deficit in knowledge is important in understanding how to improve the outcomes of 
patients in such emergencies. 
The aim of this study was to determine the knowledge of anaesthetists working in the 
Department of Anaesthesiology at the University of the Witwatersrand regarding the 
appropriate administration of adrenaline for anaphylaxis, cardiac arrest and inotropic 
infusions.  
This was a prospective, contextual, descriptive study on a sample of anaesthetists working in 
the Department of Anaesthesiology at the University of the Witwatersrand. Anaesthetists 
who were willing to participate in the study were given a brief introduction to the study and 
a questionnaire to complete regarding adrenaline doses in three different clinical scenarios. 
Data collection took place during February 2014 and June 2014. Anaesthetists’ knowledge of 
adrenaline was analysed using descriptive and inferential statistics. 
The knowledge of Wits anaesthetists regarding adrenaline use in cardiac arrest, anaphylaxis 
and as an infusion, is inadequate. A total of 104 anaesthetists answered the questionnaire 
(n=104). The pass rate for the questionnaire was 14% (n=15). The median score for the 
questionnaire was 50%.  A statistically significant difference was found between the pass 
rates of those anaesthetists who had attained an ACLS course and those who had not 
(p=0.0339). A weak correlation was found between anaesthetists knowledge and years of 
anaesthetic experience (r=0.2460). When comparing the knowledge of anaesthetists 
between different professional designations, a statistically significant difference was found 
between the intern groups’ knowledge and the consultants (33% vs 67%: p=0.0013). 
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The study questionnaire uncovered major knowledge deficits in Wits anaesthetists, and 
revealed that ACLS certification improved knowledge in anaesthetists. This study warrants 
educational intervention and future investigation into knowledge improvement. 
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CHAPTER 1: Overview of study 
1.1 Introduction 
In this chapter an overview of the study is given and will include the background to the 
study, the problem statement, aim and objectives, demarcation of the study field, ethical 
considerations, research methodology, significance of the study, research report outline 
and a summary. 
1.2 Background 
Providing healthcare is both a science and an art. The science driving this process is often 
revisited for the benefit of maintaining or improving knowledge. The implementation of 
such knowledge is the licence we work under and the art that we so intimately engage 
with. As anaesthetists, an in-depth understanding of pharmacology is required to make 
informed decisions about patient care.  
It is increasingly difficult to stay up to date with the breadth of knowledge in the field of 
anaesthesiology and related pharmacological practice, as it grows daily. Drug doses, 
effects, side-effects and interactions are crucial to the correct practice of anaesthesia, 
and especially relevant in the event of an emergency. Lack of knowledge and clinical 
experience in the event of an emergency, are a lethal combination. Adrenaline is the drug 
of choice for resuscitation during cardiovascular collapse, the dose of which should be 
tailored to the profile of the patient and clinical emergency. Incorrectly dosing patients 
with adrenaline can lead to death by overdose or by undertreating the emergent 
condition. To improve the quality of care and decrease the variation in practice (1), 
standard practice guidelines are endorsed by medical councils the world over. (2-4) 
In the anaesthetic setting, cardiac emergencies are relatively common, with international 
management protocols in place for the correct guidance of such situations (5). Although 
the causes of cardiovascular collapse may be numerous, treatment often involves the use 
of adrenaline, whether in incremental doses or as an infusion. Doses and modes of 
administration can be confusing (6) and hence the use of protocols to drive successful 
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resuscitation and ameliorate variation in treatment (1). Despite guidelines, clinical case 
studies are reported regularly, highlighting the shortcomings in physicians’ knowledge on 
the correct dosing of adrenaline (7-15). Commonly reported scenarios involve 
emergencies relating to anaphylactic events and cardiac arrest, where a standard initial 
adrenaline dose is required with or without subsequent doses or infusions, depending on 
the emergency (3, 5). 
Cases of anaphylactic shock being administered cardiac arrest doses of adrenaline have 
been reported (6). Reports of cardiac arrest patients being overdosed with adrenaline, 
leading to severe and near fatal cardiomyopathies or cardiac dysfunction, have also been 
documented (7-15). Regarding inotropic infusions, significant drug dosing errors can be 
made when preparing infusions, regardless of clinical experience (16).  No studies were 
identified with regard to inadequate doses being given as infusions. This highlights the 
importance, not only of resuscitation protocols but also the physician’s knowledge of and 
adherence to such guidelines. 
Cabana et al. (17) have shown that the implementation of emergency protocols and 
standard practice guidelines has had a limited effect on the behavioural change of 
physicians (18-20), identifying attitude as the major barrier to physician’s adherence to 
protocol based practice (17). Other barriers include physician knowledge and behaviour, 
which affect the ability of the physician to successfully execute emergency protocols (17). 
1.3. Problem statement 
Doctors specialising in anaesthesiology are expected to know the appropriate 
resuscitation guidelines regarding the use of adrenaline for anaphylaxis, cardiac arrest 
and inotropic infusion.  In each scenario specific doses and routes of administration are 
recommended (3, 4). It was not known if anaesthetists working in the Department of 
Anaesthesiology, at the University of the Witwatersrand (Wits) knew how to 
appropriately administer adrenaline in an emergency. 
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1.4. Aim and objectives 
1.4.1 Aim 
The aim of this study was to determine the knowledge of anaesthetists working in the 
Department of Anaesthesiology at Wits regarding the appropriate administration of 
adrenaline for anaphylaxis, cardiac arrest and inotropic infusions. 
1.4.2 Objectives 
The primary objectives of this study were to:  
 describe the knowledge of anaesthetists regarding adrenaline doses in three 
different clinical scenarios 
 compare whether the overall knowledge of anaesthetists, with and without ACLS 
certification, regarding adrenaline was adequate 
 compare whether the knowledge of anaesthetists, with and without ACLS 
certification, regarding each scenario was adequate 
 correlate knowledge of adrenaline with years of anaesthetic experience 
The secondary objective was to: 
 compare the knowledge of anaesthetists between different professional 
designations. 
1.5. Research assumptions 
The following definitions were used in the study: 
Anaesthetist: in this study, an anaesthetist refers to all doctors (interns, medical officers, 
registrars, and consultants) who were working in the Department of Anaesthesiology. 
Professional designation: in this study, the anaesthetist’s rank in the department e.g. 
intern, is defined as the professional designation. 
Intern: a qualified doctor who has not yet completed their internship, and who was busy 
completing the required training in the Department of Anaesthesiology. 
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Medical officers: a qualified doctor who was registered with the Health Practitioners 
Council of South Africa (HPCSA) as an independent practitioner practicing anaesthesia 
under specialist supervision. A distinction was made between junior medical officers and 
career medical officers. Career medical officers were considered as consultants. 
Registrars: a qualified medical doctor who was registered with the HPCSA as a registrar in 
the specialty of anaesthesiology. 
Consultants: any anaesthetist who has completed the required South African College of 
Medicine examinations and who is registered with the HPCSA. Career medical officers 
were included in this category. 
Knowledge: in this study, knowledge refers to the medical knowledge that a physician 
possesses regarding standard practice guidelines, protocols and algorithms relating to 
adrenaline. 
Adequate knowledge: in this study an overall score of 80% and above is considered 
adequate knowledge (pass mark). Adrenaline is a drug often used in emergencies. 
Adequate knowledge in emergencies has previously been defined as 80% and above (21).  
1.6 Demarcation of study field 
This study was conducted in the Wits Department of Anaesthesiology. Wits Medical 
School is affiliated with: Chris Hani Baragwanath Academic Hospital, Charlotte Maxeke 
Johannesburg Academic Hospital, Helen Joseph Hospital, Rahima Moosa Mother and 
Child Hospital and The Wits Donald Gordon Medical Centre. 
The level of doctors within this department ranges from interns to senior consultants. 
The department has approximately 15 to 20 interns, 24 medical officers, 107 registrars, 
and 74 consultants. 
1.7 Ethical considerations 
Permission to conduct the study was obtained from the relevant authorities. This study 
was knowledge-based, using an anonymous self-administered questionnaire (Appendix 
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4). The questionnaires were voluntary and consent was implied on completion of the 
questionnaire. Care was taken to maintain anonymity and confidentiality of the 
anaesthetists involved. 
The study was conducted in accordance with the Declaration of Helsinki (22) and the 
South African Good Clinical Practice Guidelines (23). 
1.8 Research methodology 
1.8.1 Research design 
This study was prospective, contextual and descriptive. 
1.8.2 Study population 
The study population consisted of anaesthetists working in the Department of 
Anaesthesiology at Wits. 
1.8.3 Study sample 
In consultation with a bio-statistician a sample of 85 anaesthetists was estimated and a 
convenience sampling method was used. 
1.8.4 Inclusion and exclusion criteria 
All anaesthetists who attended the weekly academic meetings and who were willing to 
participate in the study were included. Incomplete questionnaires returned were 
included and a score of zero was allocated to unanswered questions. 
Blank questionnaires returned were excluded. 
 
 
 
6 
 
1.8.5 Data collection 
Development of questionnaire 
No questionnaires pertaining to the appropriate administration of adrenaline were 
identified in the literature. A draft questionnaire based on a review of the literature was 
developed.  
The self-administered questionnaire (Appendix 4) consisted of two sections. Section 1 
included the demographic data. Section 2 consisted of questions regarding the 
knowledge that anaesthetists have on the dose and route of administration of adrenaline 
in the three scenarios. 
Data collection process 
Data was collected during February and June 2014. 
Before distribution of the questionnaires, all sheets were numbered so as to keep track of 
questionnaires completed. 
Questionnaires were distributed and anaesthetists decided whether to participate or not, 
following a brief introduction to the study aim and objectives. Those who agreed to 
participate received an information letter (Appendix 3) along with the questionnaire 
(Appendix 4). 
After completion of the questionnaire, the participant placed the questionnaire into an 
envelope, sealed it and dropped it into a collection box. This ensured anonymity and 
confidentiality of the anaesthetists participating in the study. 
1.8.6 Data analysis 
Using Microsoft Excel 2010, data was captured onto spreadsheets. The statistical 
program, GraphPad InStat, was used to analyse data. 
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1.9. Significance of the study 
Adrenaline is the most commonly used emergency drug. The incorrect dose of adrenaline 
may cause the death of the patient, an inadequate dose may not correct the 
cardiovascular collapse and an overdose may lead to myocardial infarction, lethal 
dysrhythmias and cerebrovascular accidents (6, 8-10, 14, 24-26). Therefore, it is 
detrimental to patient safety if adrenaline doses are not known. 
Case studies, the world over, have documented incidents of inappropriate adrenaline 
doses in situations ranging from anaphylaxis to cardiac arrest (6-11, 14, 15, 27). The cause 
of this is thought to be deficits in doctors’ knowledge of adrenaline (17, 25). For this 
reason it was imperative that the current knowledge of anaesthetists working in the 
Department of Anaesthesiology at Wits was determined. The results from this study may 
contribute to the awareness of anaesthetists’ correct use of adrenaline, which may 
influence patient safety. 
1.10. Validity and reliability of the study 
Measures were put into place to ensure the validity and reliability of this study. 
1.11. Research report outline 
The report will be discussed as follows: 
Chapter 1: Overview of study 
Chapter 2: Literature review 
Chapter 3: Methodology 
Chapter 4: Results and discussion 
Chapter 5: Summary, limitations, recommendations and conclusion 
1.12. Summary 
This chapter gave an overview of the study background, the problem statement, aim and 
objectives, demarcation of the study field, ethical considerations, research methodology, 
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significance of the study, and a research report outline. Chapter 2 follows with the 
literature review. 
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CHAPTER 2: Literature Review 
2.1 Introduction 
In this chapter, the literature regarding adrenaline knowledge of anaesthetists will be 
discussed. The literature review will give background to the problem at hand, and then 
discusses the anatomy and physiology of adrenaline as well as the pharmacology 
important to understanding adrenaline. To contextualise adrenaline use in anaphylaxis, 
cardiac arrest and as an infusion, the importance of adrenaline will be deliberated, with 
reference to the significance of knowing the correct doses and an attempt at explaining 
the possible reasons for dosing mistakes in each context. A brief discussion on the way 
that knowledge and attitude affects behaviour will also be explored. 
2.2 Background 
Anaesthetists need to have an in-depth understanding of pharmacology to make 
informed decisions about patient care. This has become increasingly difficult as the 
breadth of knowledge in anaesthesia and related pharmacological practice grows daily. 
Drug doses, effects, side-effects and interactions are crucial to the correct practice of 
anaesthesia, and especially relevant in the event of an emergency. During the 
management of an emergency situation, lack of knowledge and clinical experience are a 
lethal combination. Adrenaline is often the drug of choice for resuscitation during 
cardiovascular collapse. Anaesthetists, however, use exogenous adrenaline in everyday 
clinical practice for vasoconstriction and inotropic support during cardiac arrest and 
anaphylaxis. Although these life threatening emergencies are infrequent, the correct 
management using adrenaline needs to be known. The incorrect dose of adrenaline may 
cause the death of a patient.  An inadequate dose may not correct the cardiovascular 
collapse, and an overdose may lead to myocardial infarction, lethal dysrhythmias and 
cerebrovascular accidents. (28) 
For this reason, under standard practice guidelines, many international institutions use 
algorithmic protocols for the specified emergency. Training of anaesthetists in South 
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Africa is less protocolled and therefore the extent of the anaesthetists’ knowledge of the 
doses of adrenaline in emergencies is not known. 
Clinical practice guidelines are defined as, “systematically developed statements to assist 
practitioner and patient decisions about appropriate health care for specific clinical 
circumstances” (24). Knowledge of standard practice guidelines is extremely important. In 
emergencies, practical implementation of the guideline not only prompts efficient 
treatment of the patient, but also improves the quality of care and decreases the 
variation in practice so often seen with doctors (1, 29). For the anaesthetist, this means 
that in the event of an emergency, one is able to reliably treat patients where a reversible 
cause exists. However, despite clinical practice guidelines, case reports document the 
inappropriate use of adrenaline in various circumstances, often with detrimental effects 
(6, 8-11, 14, 15, 25).  
In order to use adrenaline safely it is important to understand the relevant anatomy and 
physiology of endogenous adrenaline. 
2.3 Anatomy and physiology of adrenaline 
Adrenaline is a naturally occurring catecholamine. It is actively secreted by the adrenal 
glands in response to splanchnic nerve stimulation during times of stress. There are two 
adrenal glands, each situated on top of a kidney. They comprise two main endocrine 
organs, the adrenal medulla, which secretes catecholamines and the adrenal cortex, 
which secretes mineralocorticoids. For the purpose of this literature review, only the 
adrenal medulla will be discussed. (30) 
The adrenal medullas originate from neural crest cells and essentially consist of modified 
nervous tissue. This collection of postganglionic sympathetic neurones does not have 
axons and comprise of two types of chromaffin cells, which secrete adrenaline and 
noradrenaline respectively. Chromaffin cells are responsible for the production and 
release of the catecholamines, which includes noradrenaline. In addition to adrenaline 
release, the adrenal medulla is also responsible for the conversion of noradrenaline to 
adrenaline. The medulla receives blood from the adrenal cortex, already rich in 
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corticosteroids, thus enhancing the production of the enzyme responsible for the 
conversion process. Within the medulla up to 80% of circulating noradrenaline is 
converted to adrenaline. However, noradrenaline is also released locally at tissue level. 
(30) 
The mechanisms of action of catecholamines are complex, and depend on what receptors 
are found on target organs and what the affinity the receptor has for adrenaline or 
noradrenaline (31). To explain this, a brief overview of the autonomic nervous system 
(ANS) is required. 
2.3.1 The Autonomic Nervous System 
The ANS (Figure 2.1) is part of the peripheral nervous system and therefore acts below 
ones level of consciousness to control visceral function and maintain cardiovascular 
homeostasis. Classically the ANS is divided into the parasympathetic nervous system 
(PNS), sympathetic nervous system (SNS) and enteric nervous system (ENS). The medulla 
oblongata in the brainstem is responsible for the control of this system, specifically the 
nucleus tractus solitarius (NTS), the vasomotor centre (VMC), and the cranial origin of the 
vagus nerve (31).  For the purpose of this study the SNS will be discussed. 
 
Figure 2.1 Schematic overview of the autonomic nervous system (31) 
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2.3.2 The SNS: Neural output 
Control of the SNS is mediated by aortic and carotid sinus baroreceptors, which form part 
of a reflex connecting to the NTS. The NTS is rich in noradrenergic cell bodies and nerve 
endings and hence stimulation of the reflex affects blood pressure, heart rate, blood 
vessels and the renin-angiotensin aldosterone system (RAAS). The vagus nerve and VMC 
are controlled by the NTS to affect blood pressure in the following ways. If a 
normotensive individual has raised blood pressure, the vagus nerve is stimulated to cause 
bradycardia. This is initiated by a feedback mechanism via aortic mechanoreceptors that 
respond to stretch when blood pressure rises. Furthermore, the VMC, which is 
constitutively active, is inhibited to decrease sympathetic output to peripheral blood 
vessels. During hypotension, the opposite occurs. (30) 
2.3.3 The SNS: Neurotransmitters 
Noradrenaline, adrenaline and dopamine are involved in controlling the SNS. 
Nerve terminal endings of adrenergic nerve fibres produce local noradrenaline in their 
axoplasm. This is the main neurotransmitter at postsynaptic nerve endings. This process 
is completed inside the secretory vesicles of the same cell. Its production begins with 
tyrosine’s hydroxylation to dihydroxyphenylalanine, which is then decarboxylated to 
dopamine. Dopamine is then transported into the vesicles of nerve terminals where it is 
further hydroxylated to noradrenaline. These vesicles are bubble shaped granules and 
arise from the Golgi apparatus near the nucleus of the cell. (30, 32) 
The methylation of noradrenaline, by phenylethanolamine N-methyltransferase, is 
responsible for the production of adrenaline, which occurs in the medulla of the adrenal 
glands. When splanchnic nerves are stimulated, acetylcholine is released from the 
sympathetic fibres that terminate in the adrenal medulla. This stimulates the release of 
catecholamines from membrane bound vesicles in the adrenal glands, into the 
bloodstream, and henceforth exerts their action. (30-32) 
Catecholamines have a very short half-life in blood, about 10 to 20 minutes. 
Catecholamines are metabolised in the following ways; degradation by catechol-O-
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methyltransferase (COMT) in extra-neuronal tissue, reuptake into the nerve terminal or 
degradation by monoamine-oxidase (MAO) in nerve endings. MAO’s are bound to the 
mitochondria of cells and are found in abundance at noradrenergic nerve terminals, liver 
cells and intestinal epithelium. This explains why exogenous catecholamines are not 
active if taken orally, as deamination would occur before allowed to circulate 
systemically. The by-products of catecholamines are metanephrines and vanillyl mandelic 
acid, all of which are renally excreted. (30) 
2.3.4 Receptors 
Two main groups of receptors exist in the ANS, cholinergic and adrenergic receptors. For 
the purpose of this review, only adrenergic receptors will be discussed as these are of 
significance to the mechanism of action of adrenaline. (30, 31) 
Adrenergic receptors 
This is the main group of receptors through which adrenaline exerts its action. They are 
divided into two major groups, alpha (α) and beta (β). (31) 
The α-receptors comprise two groups, the α1 and α2 subtypes, which are post-junctional 
and pre-junctional respectively.  
The α1-receptors are found on heart muscle and blood vessels coupled to G stimulatory 
proteins (Gs). Since this G protein-coupled receptor is coupled to the inositol 
triphosphate (IP) second messenger system, it will activate phospholipase C, thus 
increasing the production of IP that causes increased calcium levels. It is the binding of 
calcium to calmodulin that leads to actin-myosin coupling and therefore contraction. The 
overall cardiovascular effect is through increasing total systemic vascular resistance, 
which in turn assists in the venous return of blood. This increases the preload to the right 
side of the heart raising the blood pressure. (31) 
The α2-receptors are found pre-synaptically and post-synaptically. They occur in the 
central nervous system, nerve terminals, pancreatic islets, platelets and vascular smooth 
muscle. There are three major effects of α2-receptor agonism. They act as auto-receptors 
14 
 
on presynaptic nerve terminals to decrease noradrenaline release, this works through 
negative feedback. In the brain, α2–receptors are associated with reduced sympathetic 
outflow and are found post-junctionally. Stimulation of α2-receptors causes decreases in 
cyclic adenosine monophosphate (cAMP) production with effects that may differ in the 
central versus the peripheral nervous system. (31) 
In the central nervous system stimulation of the receptors causes vasodilation by 
decreasing outflow from the sympathetic tract. Additionally, they promote sedation, 
hypnosis, analgesia and neuroprotection, while modulating cognition, mood, sensory 
processing and locomotor activity. Stimulation of α2-receptors centrally will also supress 
shivering. (31) 
Peripherally, α2-receptors cause vasoconstriction, and are found on arteries and veins. In 
pancreatic cells they inhibit insulin secretion and on lipocytes they inhibit lipolysis. In the 
gastrointestinal system, the receptors’ stimulation results in sphincter contraction, 
glucagon release and decreases intestinal motility. (31) 
The effects described are important as they summate the fight or flight response 
associated with surges in adrenaline and noradrenaline during a stress response (32). 
β -cells are divided into three groups:  
 β 1 in cardiac muscle 
 β2 in peripheral receptors 
 β3 in lipocytes. (31) 
The β1-receptors are coupled with G-stimulatory proteins (Gs). Gs protein-coupled 
receptors use cAMP as their second messenger system. Stimulation of these receptors 
therefore results in the conversion of adenosine triphosphate (ATP) into cAMP by 
activation of adenyl cyclase. This activates protein kinase A, which in turn phosphorylates 
a series of cascade proteins that activate a cellular reaction depending on the type of cell 
stimulated. Of importance are cardiomyocytes where cAMP activation will result in a 
positive inotropic effect because of the influx of calcium into the cell. In addition to this 
action the renin-angiotensin-aldosterone system is also activated to increase the 
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absorption of sodium and therefore water by the kidneys. This assists in increasing the 
blood volume and hence blood pressure. (31) 
The β2-receptors are also coupled to the cAMP-dependant pathways but through a G-
inhibitory (Gi) receptor. Thus the downstream effects here are seen to be a reduction in 
cytosol Ca2+ found in smooth muscle and thus an overall vasodilator effect. In addition to 
the vascular effect they are also important in the lungs where they act again on smooth 
muscle of the bronchial tree, therefore mediating a bronchodilator effect when 
stimulated. (31) 
2.4 Pharmacology of adrenaline 
The structure of adrenaline (Figure 2.2) is important as the activity of the molecule is 
rendered by specific chemical moieties. This dictates the clinical effect on target organs. 
All catecholamines are β phenylethylamines, meaning that they have sympathomimetic 
activity. The hydroxyl groups found at positions three and four of the phenyl ring is 
important because: 
 they confer maximum intrinsic activity at α and β receptors; 
 it makes the molecule more water soluble and hence cannot cross the blood: 
brain barrier; 
 it allows breakdown by COMT and MAO. (31) 
Adrenaline differs from the other catecholamines in that it has an additional methyl 
substitution on nitrogen, increasing its affinity for α-receptors. The aliphatic side chain 
(hydroxyl group) renders adequate β-adrenergic affinity as well, thus making it a better 
stimulant of both α and β-adrenergic receptors than noradrenaline. Adrenaline has a 
greater affinity for α and β-receptors than that of noradrenaline. Furthermore, β-carbon 
substitutions reduce the central stimulant effect and increase its potency. (31) 
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Figure 2.2 The Adrenaline Molecule (31) 
Adrenaline’s half-life is merely 18 minutes and duration of action no longer than two 
minutes. Therefore an infusion is imperative if a prolonged duration of action is required. 
(31) 
Adrenaline is indicated for the use as an exogenous agent when cardiovascular support is 
needed i.e. during shock, arrest, anaphylaxis and cardiac bypass. This is because α and β 
effects are such that they provide positive inotropy, dromotropy and bathmotropy in the 
heart. Also, the vasopressor and vasoconstrictor effects assist in cardiac support. In the 
lungs β2-receptor stimulation relieves severe bronchospasm and α-receptor mediated 
vasoconstriction helps reduce oedematous tissues of the upper airway. (31) 
Some acute indications for use are thus as follows: 
 anaphylactic shock 
 cardiac arrest 
 vasopressor 
 inotropic infusion 
 laryngeal oedema 
 asthma. (4, 31) 
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The use of adrenaline in anaphylactic shock, cardiac arrest and inotropic infusions will be 
the only topics expanded on, as they are clinically relevant to this discussion.  
2.5 Anaphylaxis 
2.5.1 Overview 
Anaphylactic reactions are relatively common medical emergencies, with an estimated 
world incidence rate of 0.5-2%. In South Africa, the incidence is not known, as there are 
limited allergy specialists to service a population over 47 million and limited data 
collection. (33-36) 
Anaphylaxis is an acute systemic immune hyper-reaction that may present with a 
multitude of life threatening signs and symptoms. Clinically, anaphylaxis causes 
vasodilation, fluid extravasation, smooth muscle contraction and increased mucosal 
secretions. Cardiovascularly, this results in hypotension from massive vasodilatation, fluid 
shifts and myocardial depression. In the lungs and respiratory system, upper airway 
angioedema, bronchospasm and mucous plugging all lead to hypoxemia. (37) 
2.5.2 Anaphylaxis in anaesthesiology 
In anaesthesiology, anaphylactic reactions are common because many drugs causing 
allergies are given by anaesthetists. These include neuromuscular blocking agents 
(suxamethonium and rocuronium), β-lactam antibiotics, opiates (morphine), non-
steroidal anti-inflammatories and intravenous fluids (e.g. Gelofusine® and Hartmann’s 
solution). Therefore, the anaesthetist needs to be alert to the possibility of anaphylactic 
reactions on the operating table, especially since it is more difficult to recognise while 
under the influence of anaesthetic volatile agents. Early recognition and the prompt 
initiation of life saving adrenaline are crucial in the acute treatment of anaphylaxis. (38) 
The time from exposure to collapse is variable, with life threatening symptoms occurring 
as quickly as five minutes. Therefore, prompt diagnosis and emergency medical 
treatment is required, often with the use of particular modes of administration and 
specific doses of adrenaline. (38) 
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2.5.3 Treatment of anaphylaxis 
Adrenaline is the first line of treatment in severe anaphylaxis, and is the only drug with 
proven lifesaving properties (39). Adrenaline is used for treating cardiopulmonary 
collapse, caused by anaphylactic reactions, by acting on adrenoreceptors to cause: 
 vasoconstriction, decreased mediator release and decreased mucosal oedema 
(α1-adrenergic receptor); 
 bronchodilation (α1 and β2-adrenergic receptors); 
 positive inotropic and chronotropic effects on the heart (β1-adrenergic receptor). 
(37, 38) 
The Allergy Association of South Africa (ALLSA) and the Resuscitation Council of Southern 
Africa recommend the general management of 0.3-0.5 mg of adrenaline, given 
intramuscularly in the anterolateral aspect of the thigh (vastus lateralis) in the event of an 
acute unstable anaphylactic reaction in patients above six years of age. For children aged 
between two and five, 0.2 mg of adrenaline should be administered as above, and for 
infants aged less than two years, 0.1 mg is appropriate. The above-mentioned doses of 
adrenaline should never be given intravascularly for anaphylaxis as they may lead to 
angina, ischaemia and even cardiac arrest. Adrenaline should also never be given 
subcutaneously as its absorption is delayed and unpredictable. (2, 3) 
In anaesthesiology, the preferred route is intravenous and doses of all drugs are 
administered based on calculating the unit of drug needed per kilogram body weight. In 
the context of adrenaline, this is particularly important as adrenaline acts differently at 
different doses. As mentioned under adrenergic receptors, lower doses (≤0.05 
µg/kg/min) of adrenaline favour β-receptors in a ratio of β2:β1 of 10:1. This effector 
response will cause unfavourable vasodilation worsening hypotension and provoking 
cardiac arrest. Higher doses (≥0.1 µg/kg/min) favour α-receptor activation and thus 
provide vasoconstriction needed to support venous return and hence cardiac output. 
Therefore, for anaphylactic shock, a weight specific dose of 0.03-0.2 µg/kg is given as 
boluses, to titrate the drug to its clinical effect, and with subsequently larger doses on 
consecutive boluses. Should a patient require inotropic infusion doses, a rate of 0.05 
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µg/kg/min is appropriate as an intravenous infusion through a central venous catheter.  
(31) 
2.6 Cardiac arrest 
Cardiac arrest refers to the cessation of mechanical activity in the heart because of 
dysrhythmias in the heart or electromechanical dissociation (28). An arrest situation has 
numerous causes, of which, some are reversible. These include: 
 hypovolaemia 
 hypoxaemia 
 acidosis 
 hypo/hyperkalaemia 
 hypothermia 
 tension pneumothorax 
 cardiac tamponade 
 toxin ingestion 
 pulmonary and cardiac thrombosis. (4, 5) 
The dose of adrenaline in cardiac arrest, stipulated by Advanced Cardiac Life Support 
(ACLS) guideline, is a 1 mg bolus (7.5-15 µg/kg), in an adult, administered intravascularly 
every 3-5 minutes from the onset of cardiopulmonary resuscitation (CPR). (5) 
Management of cardiac arrest with the rapid onset of CPR and adrenaline has been 
proven to facilitate the return of spontaneous circulation (ROSC) and thus improve short 
term survival (5). Adrenaline assists in the ROSC by augmenting coronary blood flow that 
CPR generates. By increasing peripheral vascular tone through α1-adrenergic receptor 
stimulation, adrenaline assists with the venous return of blood to the right side of the 
heart while increasing aortic pressure and therefore coronary blood flow is facilitated. 
Without adequate coronary perfusion pressures, i.e. 15-20 mmHg, ROSC is not possible 
(28). 
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2.6.1 Overdosing in cardiac arrest 
During a resuscitation attempt, it is easy to lose track of the timing between adrenaline 
doses thus leading to the overdosing of adrenaline i.e. giving more than the 
recommended dose of adrenaline (7.5-15 µg/kg). While this may augment ROSC, the long 
term detrimental effects have been well described (5, 40). 
Adrenaline stimulates tachycardia, increases myocardial oxygen demand and stimulates 
the formation of tachyarrhythmias (28, 41). Furthermore, adrenaline activates platelet 
activity and promotes thrombogenesis (42). In the patients suffering from arrest 
situations due to acute coronary syndromes, this may cause coronary ischaemia to 
worsen (28). Overall, adrenaline may cause myocardial dysfunction by depleting 
myocardial ATP stores and increasing lactate accumulation (43). In addition to 
contributing to myocardial dysfunction in the recovery phase post-arrest, adrenaline also 
prolongs ischaemia peripherally, thereby causing persistent reductions in micro vascular 
flow (44). This has implications for the perfusion of vital organs and explains why 
adrenaline does not improve survival to hospital discharge and neurological status at 
discharge (45). 
Persistent signs of hypo-perfusion post-ROSC in cardiac arrest patients are associated 
with the total dose of adrenaline administered during CPR. Therefore, overdosing of 
adrenaline in cardiac arrest has clinically relevant implications post-arrest, and ultimately 
impacts on survival despite successful resuscitation. (28, 40, 46) 
2.7 Inotropic infusions 
Infusions of adrenaline are sometimes necessitated by persistently low blood pressures. 
This may be in the context of post arrest-ROSC, for refractory hypotension in anaphylaxis 
or as a part of an anaesthetic plan for the critically ill patient. 
Regardless of the circumstances, adrenaline infusions are prescribed at a rate, in weight 
dependant doses. An infusion of adrenaline required to support mean arterial pressures 
needs to be administered at a rate of at least 0.05 µg/kg/min and can be titrated upward 
to effect. Infusions lower than the recommended rate will tend to favour more β-
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adrenergic receptors and thus favouring unwanted peripheral vasodilation. Using doses 
above 0.5 µg/kg/min is not recommended as it may cause myocardial ischaemia, 
ventricular dysfunction, dysrhythmias or reductions in renal perfusion. (4, 31)  
2.8 The importance of doses 
Anaesthetists practice under the premise that they are familiar with the resuscitation 
algorithms presented by the American Heart Association and endorsed by the 
Resuscitation Council of Southern Africa (4, 47). This ensures that in the event of cardiac 
arrest a rapid resuscitation response ensues. This requires the anaesthetist to be astute 
and confidently apply the knowledge required to save a life. It is in the emergency 
scenario that a doctor’s knowledge and ability is truly tested, unfortunately not always 
successfully. 
The correct doses and modes of administration of adrenaline are often contested 
amongst doctors, leading to “judgement calls” being made by the doctor in charge of the 
resuscitation. This may be due to the lack of knowledge, lack of agreement concerning 
that knowledge or inexperience with the pending emergency. It is therefore important to 
understand why the correct doses are administered during anaphylactic reactions, 
cardiac arrest and inotropic infusions. These will now be discussed. 
2.8.1 In anaphylactic reactions 
The incorrect administration of adrenaline doses in anaphylaxis has been documented by 
many case reports (8-13, 15). Mistakes are usually as a result of overdosing of adrenaline 
and have led to cases of cardiogenic shock, myocardial infarction and ventricular 
tachyarrhythmia’s (6). 
In 2010 Kanwar et al (6) reported on three cases of inadvertent overdose with adrenaline, 
at a hospital in Detroit, due to confusion over the dose and route of administration (6). 
The three cases involved anaphylactic emergencies where all cases were given 
intravenous adrenaline at inappropriate doses i.e. the doses were too high. In two cases 
0.3 mg of adrenaline was correctly prescribed, but were administered intravenously. Both 
of the patients subsequently developed acute ST segment elevation myocardial infarction 
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for which they were successfully treated. In the third case, a man was given the cardiac 
arrest dose of adrenaline (1 mg) intravenously instead of the anaphylactic intravenous 
dose of 0.1 mg. He developed hypotensive shock secondary to ventricular tachycardia 
that was self-limiting and he recovered within a night in the intensive care unit. (6) 
In 2010, Droste and Narayan (25) describe a near fatal event involving adrenaline.  Again, 
1 mg of adrenaline was administered intravenously by a junior doctor, under senior 
instruction, to a man suffering from anaphylaxis subsequent to receiving intravenous 
antibiotics. He suffered acute coronary vasospasm.  
A short survey, by Droste and Narayan (48), was conducted in 2012 on hospital doctors, 
in a large district hospital in the north of England to determine their knowledge of 
adrenaline administration during anaphylaxis. The study was conducted on both junior 
and senior level doctors, working in General Medicine, General Surgery, Emergency 
Medicine, and Orthopaedics. It was found that only 15.5% of doctors would administer 
adrenaline correctly (dose and route) as recommended by the guidelines. Therefore, 
doctors of all grades and specialties were deficient in knowledge regarding the 
administration of adrenaline for acute anaphylaxis.  
The detrimental effect of adrenaline overdose highlights the significance of knowing the 
correct doses of adrenaline in emergency situations such as anaphylaxis and cardiac 
arrest. This is supported by the evidence showing that half of all fatal anaphylactic 
reactions are iatrogenic and that the mean time to cardio-pulmonary arrest is less than 
five minutes in iatrogenic anaphylactic reactions (49). 
2.8.2 In cardiac arrest 
There is little literature around cases of inappropriate dosing in cardiac arrest, although 
there is literature showing the detrimental effects of overdosing with adrenaline in 
cardiac arrest, as highlighted in section 2.6.1 (28, 40-43, 45).  
It is unequivocal that understanding adrenaline doses requires doctors to be able to 
correctly dilute their own syringes of adrenaline for administration in anaphylactic and 
cardiac resuscitation as well as for patients requiring inotropic support. 
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2.8.3 Dosing in infusions 
Dosing errors regarding infusions are common. The incorrect concentration of adrenaline 
can easily be administered simply by making a dilution error. In 2012, Adapa et al (16) 
investigated variability in the preparation of infusions in the intensive care unit in 
Cambridge and found that adrenaline infusions prepared de novo were done so with 
much less precision. Importantly, doctors who are inexperienced in diluting drugs may 
not know how to correctly do so and therefore unintentionally give an incorrect infusion 
dose. (16) 
In the intensive care unit, where drugs are mainly given as infusion, drug dosing errors 
are common. Patients in intensive care are at an estimated risk of 10% per day regarding 
dosing errors (50, 51). This has been attributed to mistakes made through preparation of 
drugs, inadequate mixing, fatigue, excessive workload and inexperience among staff (50, 
52-54). 
Rolfe and Harper (13) showed, in 1995, that junior doctors were unable to make simple 
drug dose calculations regarding lignocaine. Doctors were asked to convert between 
mass concentration, dilutions and percentage concentration, with 50% failing to do so. 
This highlights the shortcoming of some junior doctors and reiterates the possibility that 
drug infusion doses, such as adrenaline, are incorrectly prepared. (13) 
Incorrect adrenaline dosing by doctors appears to be an international problem. Surveys 
regarding South African doctors’ and anaesthetists’ knowledge on the doses of adrenaline 
in the acute emergency scenario have not been identified, necessitating investigation.  
2.9 The reasons for dosing errors 
The contributions to dosing errors are multifactorial. Anaesthetists make drug 
calculations daily for a variety of patients dependent on their weights (neonates to obese 
adults). Inadequate knowledge of adrenaline dosing, route of administration and 
calculation errors appears to be the most frequently encountered problems (6, 25). 
However, studies have also shown that doctors are unable to identify dilutions of 
adrenaline preparations and/or prepare the dilutions themselves (13, 55). This might be 
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due to confusing pharmacological labelling (56), a lack of formal training in serial dilution, 
and inexperience in the regular use of emergency adrenaline (50, 52, 54, 57). 
In a randomised controlled trial in 2008, Wheeler et al (56) investigated the effect that 
pharmacological labelling might have on the clinical performance of physicians when 
faced with simulated emergencies. In the study, physicians had to prepare an appropriate 
dilution of adrenaline for a child with anaphylaxis secondary to a peanut allergy. Results 
of this study showed that physicians are more likely to make dosing errors when the 
adrenaline vials used to prepare the dilutions were expressed as a ratio i.e. as 1 ml of 
1:1000 (56). Moreover, when physicians were asked to give the dose in milligrams of the 
dilutions of adrenaline they had prepared, they did not know how to do this. This is 
despite their knowledge of anaphylactic doses e.g. an adult should receive 0.5 ml of 
1:1000 adrenaline (26). 
It is an unspoken assumption that anaesthetists are able to correctly dilute drugs. This is 
done on a daily basis. In a 2013 study by Stucki et al (58) assessing the accuracy of 
intravenous drug preparations by anaesthetists, the investigators analysed the contents 
of unused syringes. Their findings showed that only two thirds of the total syringes 
sampled were within the dose accuracy range, allowing for variation up to 10% outside 
the concentration specified. Imprecise preparation practices and dilution errors were 
identified as the causes of the drug dose discrepancies.   
Dosing errors are common amongst doctors and have significant consequences for the 
practice of anaesthesiology. The emergency scenarios, cardiac arrest and anaphylaxis, are 
not common occurrences and therefore the knowledge doctors acquire to treat these 
conditions are subject to fade (59). Although the focus of this topic is to discuss the 
knowledge that anaesthetists have about the use of emergency adrenaline, one cannot 
dismiss the contributing factors that either deter knowledgeable decision making or 
affect it indirectly. The affect that incorrect knowledge of adrenaline dosing has on 
patient outcomes has been discussed above. The knowledge that anaesthetists have to 
properly manage specific emergencies, also mentioned above, can essentially be 
described as a function of the known doses, preparation and routes of administration of 
adrenaline in the three scenarios outlined before. However, it has consistently been 
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shown that despite standard practice guidelines and algorithms, clinical skills and medical 
knowledge should continuously be refreshed and evaluated because of the effect of 
memory fade and the growing body of evidence-based medical knowledge (4, 59). 
The successful implementation of clinical practice guidelines, however, is not only 
dependant on the medical knowledge, but on how the physician engages with this 
knowledge. Clinical practice guidelines alone have been shown to have a very limited 
effect on the behavioural change of the practicing physician (18-20). The factors 
responsible for this are unclear, but suggestions have been made. Cabana et al (17) 
identified influences that restrict a physician from complying with guidelines and has 
termed them adherence barriers. By systematically reviewing the literature on 
knowledge, attitude and behaviour, these adherence barriers are investigated by Cabana 
et al (17). 
2.10 Adherence barriers 
Cabana et al (17) propose that in order to affect the outcomes of patients based on 
practice guidelines, the guideline has to first affect the knowledge of the physician. 
Knowledge has an effect on the attitude that the physician adopts regarding the 
proposed guideline and ultimately dictates the behavioural outcome. Any one of these 
factors may restrict the adherence of the physician to a guideline and is thus termed a 
barrier. (17) 
2.10.1 Knowledge 
Knowledge adherence barriers are cognitive factors that limit the physician from 
adequately treating patients (17). The two main cognitive factors identified by Cabana et 
al (17) are the lack of awareness of the knowledge material or protocols (60-66) and the 
lack of familiarity with knowledge (17, 60, 61, 65-67). Interestingly, of the articles that 
Cabana et al (17) reviewed on knowledge barriers, up to 10% of the doctors were not 
even aware that any guideline existed (17).  
Considering the expanding scope of knowledge that physicians must stay aware of, the 
difficulty in achieving this can be appreciated (19). Also, worldwide awareness of certain 
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guidelines (e.g. immunisation guidelines) does not guarantee the familiarity with the 
knowledge material and the application thereof. Additionally, the volumes of information 
that account for some guidelines are vast, requiring time to process the information that 
cannot be afforded to all doctors. Staying abreast with medical knowledge is also under 
the proviso that one has complete access to the information at all times, which is not the 
case when dealing with doctors working in developing countries, where resources are 
limited, if available at all (17).  
This does not explain, however, why doctors who are up to date with specialist field 
guidelines still deter from protocol despite their academic soundness. It is proposed that 
physician attitude to protocols are a major determinant of the behavioural outcome (17). 
2.10.2 Attitude 
The physician’s attitude towards practice guidelines is complex, as it involves not only a 
psychosocial aspect but is also driven by academic pride (17). Identifying attitudes that 
resist adherence has prompted much literature on resistance to adopting standard 
practice guidelines. By reviewing studies on adherence to protocols, researchers have 
attempted to identify the causes of attitude barriers. 
Lack of agreement 
Several studies have investigated the possibility that lack of agreement in the medical 
community may be an important explanation for physician non-adherence to practice 
guidelines (61, 68-71). One could argue that the lack of agreement is yet another form of 
lack of knowledge through insight, and thus not different from a knowledge barrier. 
Often the reasons for lack of agreement were shown to be due to differences in the 
interpretation of the guideline’s evidence. Also, the applicability of the guidelines to 
specific populations and the cost implications are not always practical options. 
Furthermore, it was shown that the credibility of the guideline authors was also under 
contention by some physicians. This may explain, in part, why physicians choose to exert 
their autonomy when treating patients for problems where practice guidelines exist. The 
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lack of agreement as an attitude barrier, however, is less commonly shown to be a cause 
of non-adherence to guidelines (17). 
Lack of self-efficacy 
Other attitude-related adherence barriers include the physician’s belief that one cannot 
perform the expected behaviour necessary to implement the practice guideline and belief 
that the expected outcome of the guideline will not initiate change. The belief that one 
can actually perform behaviour is known as self-efficacy and is dependent on the 
physician’s confidence in executing the skills required to deliver the practice guidelines 
adequately. (72) 
Self-efficacy influences the initiation and sustainability of behaviour despite poor 
outcomes (72). Regarding expectations of behaviour leading to a particular consequence, 
if the physician has no expectation of the guideline improving the outcome, they are less 
likely to adhere to the guideline (17). 
It is true for most that “old habits die hard”; implying that changing practice habits is a 
difficult hurdle to overcome. The practicing physician needs to be amenable to the 
changing face of medicine, but it is not easy to stay motivated to do so. This appears to 
be a problem that many physicians experience, but has not been investigated as widely as 
other attitude barriers.  
2.10.5 Behaviour 
Although attitudes are shown to affect behaviour significantly (69), it is sometimes 
external barriers that pose great implications for instituting practice guidelines. Barriers 
outside the control of the practicing physician can be an unconquerable hurdle, leading 
to non-adherence to guidelines (17). 
External barriers include: 
 guideline-related barriers 
 patient-related barriers 
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 environmental-related barriers. (17) 
Guideline-related barriers refer to the difficulty or inconvenience that the institution of 
the guideline would impose, thus rendering non-adherence (17). However, when 
guidelines prompt adding a behaviour it is shown that the guideline may be more easily 
instituted than eliminating or replacing an established behaviour (73), as this then relates 
back to the inertia of previous practice as an additional barrier to adherence (17). 
Patient related barriers pose great implications, as reconciling the patient preference for 
a practice guideline may not be possible (74). Even with complete physician knowledge, 
agreement with guidelines and self-efficacy of the implementation thereof, without 
patient agreement of the need for guideline recommendations, adherence is impossible 
(17). 
Barriers regarding resource or facility deficits are referred to as environmental-related 
factors and are beyond the physicians control (75). Additionally, physician environments 
lacking a reminder system, insufficient staff, increased practice costs and poor 
reimbursement may also be factors beyond physical control. The lack of a reminder 
system is an important barrier because managing emergencies involving adrenaline is 
subject to the constant update in current literature and algorithmic protocols (4). 
Compensation for external barriers may be possible when adequate resources or referral 
systems are in place, however this does not ensure adherence to guidelines as discussed 
above. Few studies have been able to show variety in the barriers that need to be 
overcome to achieve adherence. This is because most studies are only looking at one 
barrier to adherence, therefore restricting interventions to improve adherence. (17) 
In summary, in order to improve adherence to practice guidelines one needs to 
understand the factors influencing the desire to deviate from the recommendations. 
Cabana et al (17) have successfully highlighted the barriers that restrict physician 
behaviour in implementing practice guidelines (17). This is congruent with other research 
by Phipps et al (69, 70, 76) emphasising that attitudes and belief systems are a major 
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influence on the behavioural outcome. This is explained again by the theory of planned 
behaviour (77). 
2.11 Theory of Planned Behaviour 
The Theory of Planned Behaviour (TPB) holds the belief that three main factors are 
responsible for a person’s intention to engage in a specific behaviour (77). The first is the 
perceived outcome of the behaviour or attitude towards the behaviour. Secondly, the 
subject norm refers to the perceived expectations of others regarding the behaviour. 
Lastly, perceived behavioural control is the degree of volitional control that a person has 
over their behaviour. Interestingly, Phipps et al (76) applied this behavioural model to 
anaesthesiology consultants to identify factors that predict their intention to deviate 
from standard anaesthetic practice guidelines (76) . It was shown that attitude to 
behaviour was the most persistent influence over behaviour. Phipps et al (70) go on to re-
examine their findings in detail in a 2010 study, expanding on how individual beliefs may 
influence the anaesthetist’s behaviour in each composite TPB measure. Their findings 
were consistent with their previous work in that the results suggested that anaesthetists’ 
intention to deviate from guidelines was not an absolute, but rather a case of clinical 
judgement (69). This reflects a previous qualitative study by Phipps (76), showing that 
there is a discrepancy between what should be done in “the ideal world” versus what is 
really done in anaesthetic practice. Importantly, the behavioural intentions of the 
anaesthetist can now be predicted by the parameters discussed above. What is unclear 
however, is how far the behaviour extends. If clinicians can deviate from practice 
guidelines based on their attitude and knowledge towards the guideline, then how do 
intentions deviate when the guideline is pertaining to an emergency? 
2.12 Conclusion 
The knowledge of anaesthetists in the management of emergencies involving adrenaline 
is of critical importance, as emphasised by the above discussion. The medical knowledge 
pertaining to adrenaline starts with a basic physiological understanding of why adrenaline 
would help in the event of anaphylaxis, cardiac arrest, or as an inotropic infusion. These 
clinical scenarios are all familiar to the practicing anaesthetist. Furthermore, all scenarios 
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have algorithms that are internationally recognised and implemented to standardise the 
treatment of patients and conform management to a best possible outcome. Despite 
guidelines, doctors the world over are still getting it wrong when it comes to adrenaline 
dosing in emergencies. Understanding why this happens is multifactorial and involves the 
interaction between knowledge and behavioural attitudes. 
In order to maximise the therapeutic benefits of adrenaline-based protocols, 
anaesthetists need to be able to conform to them in the event of an emergency. 
Familiarity with the correct adrenaline doses, routes of administration and dilutions is 
also of grave importance, as it will assist in efficiently executing the implementation of 
these protocols when an emergency arises. The current knowledge of anaesthetists on 
this topic, however, is not known in South Africa. 
2.13 Summary 
Chapter two has summarised the importance of understanding adrenaline by 
anaesthetists by giving the background to the problem as well as the anatomy, physiology 
and pharmacology. Adrenaline’s importance is then highlighted in the context of three 
specific emergency scenarios, with emphasis on why giving the correct drug dose is of 
grave importance. By exploring the topics of adherence barriers and planned behaviour, 
the reasoning behind differing practices is better understood. Chapter three will now 
explain the methodology behind the study design. 
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CHAPTER 3: Research methodology 
3.1. Introduction 
In this chapter the problem statement, aim and objectives, ethical considerations, 
research methodology and the validity and reliability of the study are discussed. 
3.2. Problem statement 
Doctors specialising in anaesthesia are expected to know the appropriate resuscitation 
guidelines regarding the use of adrenaline for anaphylaxis, cardiac arrest and inotropic 
infusion.  In each scenario specific doses and routes of administration are recommended 
(3, 4). It was not known if anaesthetists working in the Department of Anaesthesiology, at 
Wits know how to appropriately administer adrenaline in an emergency. 
3.3. Aim and Objectives 
3.3.1 Aim 
The aim of this study was to determine the knowledge of anaesthetists working in the 
Department of Anaesthesiology, at Wits, regarding the appropriate administration of 
adrenaline for anaphylaxis, cardiac arrest and inotropic infusions. 
3.3.2. Objectives 
The primary objectives of this study were to:  
 describe the knowledge of anaesthetists regarding adrenaline doses in three 
different clinical scenarios 
 compare whether the overall knowledge of anaesthetists, with and without ACLS 
certification, regarding adrenaline was adequate 
 compare whether the knowledge of anaesthetists, with and without ACLS 
certification, regarding each scenario was adequate 
 correlate knowledge of adrenaline with years of anaesthetic experience 
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The secondary objective was to: 
 compare the knowledge of anaesthetists between different professional 
designations. 
3.4. Ethical considerations 
Application to the Postgraduate office (Appendix 1) and to Human Research Ethics 
Committee (Appendix 2) of the Faculty of Health Science, Wits was approved. 
This study was knowledge-based using a self-administered questionnaire (Appendix 4). 
The researcher invited participants to take part in the research. Those who agreed 
received an information letter (Appendix 3) and questionnaire (Appendix 4).The 
questionnaires were voluntary and consent was implied on the completion of the 
questionnaire. Care was taken to maintain anonymity and confidentiality of the 
anaesthetists involved. A study number was allocated to each questionnaire and placed 
in a sealed box with no identifying information being requested from the participants. 
Only the researcher and the supervisors had access to the raw data. Data will be stored 
securely for six years, following completion of the study. Based on the results of the 
study, an update on the appropriate use of adrenaline will be presented at a 
departmental academic meeting. 
The study was conducted in accordance with the Declaration of Helsinki (22) and the 
South African Good Clinical Practice Guidelines (23). 
3.5. Research methodology 
3.5.1. Research design 
Burns and Grove (78) describe a research design as the blueprint for a study. According to 
Brink (79), a research design determines the methods by which the researcher obtains 
subjects, collects data and interprets results.  
This was a prospective, contextual, descriptive study. 
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A prospective study is one in which a specific population is followed over time to observe 
an outcome (79). This was a prospective study as data was collected at departmental 
academic meetings.  
A contextual study is one which refers to a specific group or population, defined by De 
Vos (80) as a “small-scale world”. The “small-scale world” can be a ward, an intensive 
care unit or a clinic. This study was contextual because research was conducted in the 
Department of Anaesthesiology, Wits. 
According to Brink (79), a descriptive study is one in which a population’s characteristics 
are being described, so as to answer a specific question about the population, without 
attempting to establish a causal link (79). The knowledge that anaesthetists have about 
the appropriate administration of adrenaline in emergencies was described in this study. 
3.5.2. Study population 
The study population consisted of anaesthetists working in the Department of 
Anaesthesiology. 
3.5.3. Study sample 
Sample Size 
In consultation with a bio-statistician a sample of 85 Wits anaesthetists was estimated. 
This was based on the assumption that 67% of anaesthetists in the Wits Department of 
Anaesthesiology would have adequate knowledge of adrenaline to an accuracy of within 
10%, with 95% confidence. 
Sampling method 
This study used a convenience sampling method, as is appropriate for a descriptive study 
(78). 
Convenience sampling involves the sampling of participants who are readily available to 
the researcher (79). Importantly, for the purpose of this study, a sample of anaesthetists 
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who were in the same place at the same time was required in order to distribute a 
“surprise” questionnaire, thus eliminating the possibility of pre-empting answers to 
questions. This was done on two occasions several weeks apart at different hospital 
meetings, sampling from different members of the Department of Anaesthesiology. 
Inclusion and exclusion criteria 
All anaesthetists who attended the weekly academic meetings and who were willing to 
partake in the study were included. Incomplete questionnaires returned were included 
and a score of zero was allocated to unanswered questions. 
Blank questionnaires returned were excluded. 
3.5.4. Data collection 
Development of questionnaire 
Self-report techniques are used when the objective of the researcher are to determine 
what a population believes, thinks, or knows (79). An easy method to collect this data is 
by means of questionnaires 
No questionnaires pertaining to the appropriate administration of adrenaline were 
identified in the literature. To ensure content validity the draft questionnaire was based 
on a review of the literature. To further achieve face and content validity, three 
anaesthesiologists were consulted. Following consultation minor corrections were made. 
The self-administered questionnaire (Appendix 4) consisted of two sections. Section 1 
included the following demographic data: 
 years of experience in anaesthesiology 
 professional designation e.g. registrar, consultant 
 ACLS certification and date attained. 
Section 2 consisted of questions regarding the knowledge that anaesthetists have on the 
dose and route of administration of adrenaline in the following three scenarios: 
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 anaphylaxis 
 cardiac arrest 
 inotropic infusions. 
Data collection process 
Before distribution of the questionnaires, all sheets were numbered so as to keep track of 
the number of questionnaires completed. Numbering the questionnaires also helped 
prevent reproduction of results. Furthermore, a response rate could then be calculated. 
Data was collected during February 2014 and June 2014 at departmental academic 
meetings. The researcher and two assistants were present during completion of the 
questionnaires to assist with queries and prevent data contamination. To further prevent 
data contamination, the researcher collected data at non-consecutive departmental 
meetings. 
At the start of the meeting the researcher addressed anaesthetists, giving them a brief 
introduction to the study and inviting them to participate. Information letters and 
questionnaires were distributed allowing 10 to 15 minutes to complete the 
questionnaire. 
All the questionnaires, complete and incomplete, were placed in an unmarked envelope, 
sealed and dropped into a collection box. This ensured anonymity and confidentiality of 
the anaesthetists participating in the study. 
Based on the results of the study, an update on the appropriate use of adrenaline will be 
presented at a future departmental academic meeting. 
A post-test often follows an educational lecture. It was decided not to do a post-test in 
this study, as attendance at departmental meetings cannot be guaranteed as 
anaesthetists have service commitments that influence meeting attendance. The 
anaesthetists completed the questionnaire anonymously, therefore it was not possible to 
organise a post-test at an alternative time. Furthermore, Cabana et al (17) highlighted 
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that knowledge alone does not change behaviour, but it is also influenced by the doctors 
attitude. 
3.6. Data analysis 
Using Microsoft Excel 2010, data was captured onto spreadsheets. The statistical 
program, GraphPad InStat, was used to analyse data. 
The knowledge regarding doses and route of administration of adrenaline was described 
using frequencies and percentages. Knowledge of adrenaline and years of experience was 
correlated with a Spearman Rank Correlation test, and knowledge between professional 
designations was compared using the Kruskal-Wallis test, as data was not normally 
distributed. Categorical variables were compared using the Fisher’s exact test. 
A 0.05 level of significance was used. 
3.7. Validity and reliability of the study 
According to Botma (81), “Validity indicates whether the conclusions of the study are 
justified based on the design and interpretation”. 
Reliability refers to how consistent the measurements have been (81). 
The validity and reliability of this study was maintained by: 
 using a standard questionnaire with face and content validity 
 using an appropriate study design 
 the sample size being calculated in consultation with a biostatistician 
 a researcher and two assistants being present on completion of the 
questionnaires to answer any queries and prevent data contamination 
 questionnaires being completed at non-consecutive academic meetings, to 
prevent data contamination 
 questionnaires being placed anonymously into an envelope, thereby facilitating a 
non-threatening environment 
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 data being analysed with the assistance of a biostatistician. 
3.8. Summary 
In this chapter the problem statement, aim and objectives, ethical considerations, 
research methodology, data analysis and validity and reliability were discussed. In the 
next chapter the results of the study are reported and discussed. 
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 CHAPTER 4: Results and discussion 
4.1 Introduction 
The sample realisation, results of the study according to the objectives and the discussion 
are presented in this chapter. The objectives of this study are therefore repeated.  
The primary objectives of this study were to:  
 describe the knowledge of anaesthetists regarding adrenaline doses in three 
different clinical scenarios 
 compare whether the overall knowledge of anaesthetists, with and without ACLS 
certification, regarding adrenaline was adequate 
 compare whether the knowledge of anaesthetists, with and without ACLS 
certification, regarding each scenario was adequate 
 correlate knowledge of adrenaline with years of anaesthetic experience 
The secondary objective was to: 
 compare the knowledge of anaesthetists between different professional 
designations 
4.2 Results 
The findings here are described and analysed using descriptive and inferential statistics. 
Descriptive tables are used to report objectives where appropriate. Spearman’s Rank 
correlation, Fisher’s exact test and Kruskal-Wallis test are the inferential stats used to 
compare group results. P-values of <0.05 are considered statistically significant. Each 
objective is discussed separately. 
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4.2.1 Demographics 
Sample Realisation 
A total number of 105 questionnaires were distributed between the four hospitals during 
February 2014 and June 2014. Only one questionnaire was excluded as it was returned 
blank. Therefore a total of 104 questionnaires were included in the statistical analysis 
(n=104). This sample size is well above the estimated sample size of 85 needed to power 
the study with a p-value of < 0.05. 
The sample of anaesthetists consisted of 21 interns (20%), 9 medical officers (9%), 37 
registrars (35%), one career medical officer (1%) and 36 consultants (35%) In order to 
fulfil the objectives of this research report, the designated groups were re-grouped into 
three comparative groups. Interns and medical officers, with less than one year 
experience, are pooled together to comprise the first group, interns (n=26). Registrars 
and medical officers with more than one year experience comprise the second, registrars 
(n=41), and the third group is made up by adding the only career medical officer to the 
consultant group (n=37) (Figure 4.1). 
Figure 4.1 Bar graph showing the designation of anaesthetists 
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Of the 104 participants, 72 (69%) had completed an ACLS course, and 32 (31%) had never 
completed the course. Of all the participants only 19 (18%) had completed the ACLS 
course in the last two years (and were therefore certified), with 53 (51%) of participants 
having completed ACLS more than two years ago. Overall 85 (82%) anaesthetists had 
outdated ACLS course knowledge or had never attended an ACLS course (Figure 4.2). 
Figure 4.2 Flow diagram showing proportions of anaesthetists who have ACLS and 
are certified 
 
Participant information is also expressed as years of anaesthetic experience, showing that 
71 anaesthetists (68%) who took part in the study were junior anaesthetists, having less 
than five years of anaesthetic experience (Figure 4.3).  
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Figure 4.3 Bar graph showing participants’ years of anaesthetic experience 
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adrenaline (1 mg). The lowest score in the questionnaire was for question six, with 9 (9%) 
participants knowing the correct ceiling dose (0.5 mcg/kg/min) of adrenaline when used 
as an infusion. Question 2 shows that 50 (48%) participants know the cardiac arrest dose 
of adrenaline as a per kilogram dose (7.5-20 mcg/kg). In answering question 3, 63 (60.6%) 
anaesthetists knew how to correctly manage anaphylactic shock with intravenous 
adrenaline (0.03-10 mcg/kg). Question four resulted in 21 (20.2%) anaesthetists correctly 
answering an alternative route and dose for adrenaline administration in anaphylaxis (0.5 
mg IM). Question five showed that 82 (79%) participants knew how to correctly start an 
adrenaline infusion at an appropriate dose (0.05 mcg/kg/min).  
Table 4.1 Summary of the results for each scenario and question 
Scenario Scenario Pass 
Rate (%) 
Scenario 
Mean (%) 
Question Correct Incorrect 
1 46 67 1 89 (86%) 15 (14%) 
  2 50 (48%) 54 (52%) 
2 14 4 3 63 (60%) 41 (40%) 
  4 21 (20%) 83 (80%) 
3 7 44 5 82 (79%) 22 (21%) 
  6 9 (9%) 95 (91%) 
Total    314 (50.3%) 310 (49.7%) 
 
 
4.2.3 Objective: to compare whether the overall knowledge of anaesthetists, with and 
without ACLS certification, regarding adrenaline was adequate 
To compare whether or not having ever done an ACLS course would make a difference to 
the overall knowledge of anaesthetists, a Fisher’s exact test was used (Table 4.2). Of the 
72 anaesthetists who had ever completed an ACLS course 14 (19%) passed the 
questionnaire and 58 (81%) failed. Of the 32 anaesthetists who had never completed an 
ACLS course only 1 (3%) participant passed and 31 (97%) failed the questionnaire. A 
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statistically significant difference was found between these two groups (p=0.0339) with a 
greater proportion of anaesthetists passing if they had completed an ACLS course 
previously, whether their ACLS certification was current or not. Therefore, having an 
ACLS, made a difference to the overall questionnaire score the participants achieved 
(Table 4.2). 
Table 4.2 Contingency table comparing overall knowledge of adrenaline, with and 
without an ACLS certification, with pass rate 
 ACLS No ACLS Total 
Pass 14 1 15 (14%) 
Fail 58 31 89 (86%) 
Total 72 (69%) 32 (31%) 104 (100%) 
p=0.0339 
 
Although not an objective, further Fisher’s exact analysis (Table 4.3) was done to 
determine whether having a current ACLS certification, as opposed to a lapsed ACLS 
certification, had an effect on the pass rate of anaesthetists regarding the adrenaline 
knowledge questionnaire. 
Of the 72 anaesthetists who had ever acquired ACLS certification 19 (26%) were currently 
certified and 53 (74%) had allowed their certification to lapse. Of the 19 anaesthetists 
currently certified with ACLS, 5 (26%) passed the questionnaire and 14 (74%) failed. Of 
the 53 anaesthetists whose ACLS had lapsed 9 (17%) passed the questionnaire and 44 
(83%) failed. No difference was found between these groups (p=0.4999). 
Table 4.3 Contingency table comparing overall knowledge of adrenaline, with and 
without a recent ACLS certification, with pass rate 
 ACLS updated ACLS not Updated Total 
Pass 5 9 14 (19%) 
Fail 14 44 58 (81%) 
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Total 19 (26%) 53 (74%) 72 (100%) 
P=0.4999 
4.2.4 Objective: to compare whether the knowledge of anaesthetists, with and 
without ACLS certification, regarding each scenario was adequate 
Scenario 1: cardiac arrest 
Of the 104 anaesthetists, 48 (46%) participants passed the scenario and 56 (54%) failed 
(Table 4.4). Of the 72 anaesthetists who had ever completed an ACLS course 39 (54%) 
participants passed and 33 (46%) participants failed to answer correctly. Of the 32 
anaesthetists who had never completed an ACLS course 9 (28%) participants passed and 
23 (72%) failed. Using a Fisher’s exact test a significant difference was found between the 
groups (p=0.0118). Therefore, having an ACLS course improved knowledge of 
anaesthetists regarding the correct doses of adrenaline in cardiac arrest.  
Table 4.4 Contingency table comparing ACLS certified anaesthetists’ knowledge of 
cardiac arrest with those who are not certified 
 ACLS No ACLS Total 
Pass 39 9 48 (46%) 
Fail 33 23 56 (54%) 
Total 72 (69%) 32 (31%) 104 (100%) 
P=0.0118 
 
Scenario 2: anaphylaxis 
Of the 104 anaesthetists, 15 (14%) participants passed the scenario and 89 (86%) 
participants did not know the correct doses and route of administration of adrenaline in 
anaphylaxis (Table 4.5). Of the 72 anaesthetists who had ever completed an ACLS course 
14 (19%) answered the question correctly and 58 (81%) participant answered incorrectly. 
Of the 32 anaesthetists who had never completed an ACLS course 1 (3%) participant 
answered correctly and 31 (97%) answered incorrectly. Using a Fisher’s exact test a 
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significant difference was found between the groups (p=0.0339). Therefore, having an 
ACLS course improved knowledge of the route and dose of administration of adrenaline 
during an anaphylactic reaction.  
Table 4.5 Contingency table comparing the knowledge of the anaphylaxis scenario 
route and dose of adrenaline administration with ACLS certification 
 ACLS No ACLS Total 
Pass 14 1 15 (14%) 
Fail 58 31 89 (86%) 
Total 72 (69%) 32 (31%) 104 (100%) 
P=0.0339 
 
Scenario 3: adrenaline infusions 
Of the 104 anaesthetists, 7 (7%) participants passed the scenario and 97 (86%) failed 
(Table 4.7). Of the 72 anaesthetists who had ever completed an ACLS course 6 (8%) 
participants passed and 66 (92%) participants failed to answer correctly. Of the 32 
anaesthetists who had never completed an ACLS course 1 (3%) participant passed and 31 
(97%) failed. No difference was found between these groups (p=0.4331). Therefore, 
having an ACLS course did not improve anaesthetists’ knowledge of adrenaline infusions.  
Table 4.6 Contingency table comparing the knowledge of adrenaline infusion 
scenario with ACLS certification 
 ACLS No ACLS Total 
Pass 6 1 7 (7%) 
Fail 66 31 97 (86%) 
Total 72 (69%) 32 (31%) 104 (100%) 
P=0.4331 
 
Although not an objective, analysis of each question was performed using Fisher’s exact 
tests to show where the differences in knowledge are and whether or not having an ACLS 
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course improved knowledge of that question. As summarised by Table 4.7, below, 
differences were found between the ACLS and No ACLS groups for questions 1, 4 and 5. 
Therefore having an ACLS certification made answering those questions more likely, 
whereas no differences were found between the groups for the remaining questions. 
Table 4.7 Table showing the results of Fisher’s exact tests performed on each 
question from the three adrenaline scenarios 
Question ACLS 
Yes/No 
No ACLS 
Yes/No 
P-value 
1 69/3 20/12 p<0.0001 
2 38/34 12/20 p=0.2023 
3 46/26 17/15 p=0.3851 
4 20/52 1/31 p=0.0031 
5 63/9 19/13 p=0.0033 
6 7/65 2/30 p=0.7179 
 
 
4.2.5 Objective: to correlate the knowledge of adrenaline with years of anaesthetic 
experience 
To identify whether there was a correlation between anaesthetists’ knowledge of 
adrenaline and the number of years spent in anaesthetic practice a Spearman’s Rank 
correlation test was used. The participants’ years of anaesthetic experience are plotted 
on the x-axis in categories and are as follows: 1= <1 year experience, 2=1-5 years 
experience, 3=6-10 years experience, 4=11-15 years experience, 5=16-20 years 
experience and 6= >20 years experience (as per Appendix 4). Spearman’s r= 0.2460 (95% 
CI 0.05031 to 0.4236), showing a weak positive correlation (Figure 4.4), meaning that the 
greater the number of years spent in anaesthetic practice, the greater the knowledge 
that anaesthetists have regarding adrenaline doses in different clinical scenarios. This 
finding was statistically significant (p=0.0118). 
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Figure 4.4 Scatter plot showing the relationship between anaesthetists’ years of 
experience and their knowledge of adrenaline 
 
Categories: 1= <1 year experience, 2=1-5 years experience, 3=6-10 years experience, 4=11-15 years 
experience, 5=16-20 years experience and 6= >20 years experience 
 
4.2.6 Secondary objective: to compare the knowledge of anaesthetists between 
different professional designations 
The three groups were compared using inferential statistics, namely a Kruskal-Wallis test 
with Dunn’s multiple comparisons test post-hoc. The data was not normally distributed, 
so the medians of each group were compared. Of the three groups only the intern sample 
group passed the normality Kolmogorov-Smirnov test with a p-value of 0.0567 (Table 
4.8). 
Interns obtained a median score of 33 % (range: 0-83%). The registrars obtained a median 
score of 50% (range: 0-87%). The consultants obtained a median score of 67% (range: 17-
87%). Of the three groups only the scores of the interns were normally distributed, 
therefore when comparing the groups a Kruskal-Wallis test was used. A statistically 
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significant difference was found (p=0.0013) and was confirmed to be between the intern 
and consultant groups following a Dunn’s multiple comparison test (p<0.001) (Table 4.9). 
Table 4.8 Summary of the results for the comparison of knowledge between 
groups of anaesthetists according to professional designation using the 
Kruskal-Wallis Test 
Group Interns Registrars Consultants 
Sample Size 26 41 37 
Mean (%)  36.54 50 60.43 
Standard Deviation 26.68 23.87 16.76 
SEM 5.232 3.728 2.755 
Median (%) 33 50 67* 
Min (%) 0 0 17 
Max (%) 83 83 83 
Normality Test KS# 0.1681 0.1764 0.2200 
Normality Test P value 0.0567 0.0025 <0.0001 
Passed Normality Test Yes No No 
*significantly different from the intern group (p<0.001) 
# KS: Kolmogorov-Smirnov 
Table 4.9 Dunn’s Multiple Comparisons test table for group test result differences 
Comparison Mean Rank Difference P-Value 
Interns vs. Reg’s -14.896 ns  P>0.05 
Interns vs. Cons -27.386 P<0.001 
Reg’s vs. Cons -12.490 ns  P>0.05 
 
4.3 Discussion 
Wits anaesthetists’ knowledge on the use of adrenaline in different clinical scenarios is 
not adequate, since only 14% of anaesthetists who participated in the study passed the 
questionnaire. The results reflect findings by institutions worldwide who have similarly 
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attempted to determine the knowledge that doctors have on the use of adrenaline in 
different emergency scenarios (25, 48, 82-84). A study by Jose et al (82) showed that in 
2007, doctors in Wales and England were not only using the incorrect doses of adrenaline 
in anaphylaxis, but also the incorrect route of administration. Further studies by Droste et 
al (25, 48) showed that in 2010 and 2012 junior doctors in England were using inadequate 
doses of adrenaline in anaphylaxis. 
The average score of the adrenaline questionnaire across all groups of anaesthetists was 
50%, which is less than adequate in the treatment of patients in the emergency scenario. 
Discussing where the shortcomings of this knowledge are might explain why the overall 
test questionnaire scores are so poor. Therefore, it is important to discuss the results 
with regard to each question within the different clinical scenarios.  
Clinical scenario one 
In the first clinical scenario (Questions 1 and 2), cardiac arrest doses of adrenaline were 
required to correctly answer the questions. Only 46% of anaesthetists were able to 
answer both questions in the scenario and thus more than half the participants failed the 
scenario. Of the anaesthetists who passed the scenario, a significantly greater proportion 
of them were ACLS certified (p=0.0118) and therefore the likelihood of passing the 
scenario was dependant on the acquisition of knowledge from having completed an ACLS 
course. This seems obvious and yet not all ACLS certified anaesthetists passed the 
scenario. 
It was shown that for question 1, 86% of anaesthetists knew that the cardiac arrest dose 
of adrenaline is 1 mg intravenously, given as a bolus dose (4, 47). It is interesting that this 
question was not answered with a 100% pass rate since it is common knowledge amongst 
anaesthetists and most doctors (4). Possibly, the lack of knowledge regarding question 1 
has to do with the effect of memory fade suggested by Heard et al (59). Cardiac 
emergencies are also not that common and therefore, the need for constant updating of 
knowledge regarding ACLS algorithms is probably underestimated. This is supported by 
Ragavan et al (21), suggesting that emergency care knowledge should be updated every 
two years . Since 82% of the participants (Figure 4.2) did not have an ACLS certification or 
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had not updated their certification (within the last two years), their lack of knowledge 
might be attributed, in part, to memory fade. It is important to mention that physicians 
attitudes towards protocols and resuscitation knowledge also affects the dose they would 
administer in such situations (17). Reasons for this have been described by Cabana et al 
(17), and include the lack of agreement and self-efficacy, meaning it is plausible that 
incorrect answers were provided because of disagreement with the guideline’s 
recommendation.  
It is unlikely that there are anaesthetists that have not been faced with a cardiac arrest 
situation at some point in their medical careers. One could argue that, although medical 
students are trained regarding cardiac arrest scenarios, there is no exit level exam testing 
cardiac arrest doses of adrenaline at medical school, hence, room for error when faced 
with the life saving scenarios. It is important to note that ACLS is not a compulsory 
course. 
Furthermore, not all specialties require an ACLS certificate in order to become a specialist 
in training. In the Department of Anaesthesiology at Wits the questionnaire showed that 
only 69% of participants had ever completed an ACLS course. One possible reason for this 
could be that ACLS courses were not a pre-requisite for registrar posts when the more 
experienced anaesthetists began their training. Another reason could be that there were 
no consensus guidelines regarding cardiac support and thus some participants’ training 
predated the integration of such protocols (ACLS). ACLS was first developed after 
discussions held at the Third National Conference on CPR in 1979 for the first time. 
These reasons, however, do not negate the fact that there are anaesthetists who do not 
know, or are deterring from, the cardiac arrest dose of adrenaline recommended by the 
ACLS guidelines, which are an international standard.  
The fact that an ACLS course was completed should not be interpreted as having acquired 
the knowledge indefinitely, as most of the participants who acquired an ACLS certificate 
had done so more than two years prior to the answering of this research report’s 
questionnaire, and thus many of the details regarding the protocols may have been 
forgotten. This is corroborated by knowledge studies showing that the retention of 
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knowledge is only reliable if done so repeatedly throughout ones career (21, 85). Some 
recommendations include three monthly updates of vital information, in order to 
remember such protocols, and to therefore be considered up to date with current 
information. Considering that only 18% of the sample of anaesthetists had completed the 
ACLS course in the last two years may also be suggestive of the poor knowledge 
outcomes regarding cardiac arrest doses.  
In the second question, a more detailed dosing of adrenaline was required to correctly 
answer the question. For this question, the dose, per kilogram of body weight, of 
adrenaline was required to correctly answer the question (7.5-20mcg/kg). Only 48% of 
the participants correctly answered this question, indicating that there is a lack of 
understanding regarding the basis for using a single milligram bolus dose of adrenaline in 
cardiac arrest. Acquiring ACLS certification made no difference to the anaesthetists’ pass 
rate regarding this question, which is explained by the fact that ACLS does not teach the 
cardiac arrest dose of adrenaline as a body weight adjusted dose, but as a bolus dose. 
This question, however, has relevant clinical applications due to the fact that during non-
cardiac arrest scenarios, using doses in these ranges may be detrimental to patients, 
because doses as high as this may induce cardiac ischaemia and thus precipitate cardiac 
failure or even death (6, 28, 40, 43, 45).  
Clinical scenario two 
Only 14% of anaesthetists passed the anaphylaxis scenario. During anaphylactic shock, 
intravenous adrenaline administration is necessary in the range of 0.02 mcg/kg to 10 
mcg/kg (31). The results of question 3 in the knowledge study show that 60% of 
anaesthetists know how much adrenaline to administer during such an emergency. 
Results of this question ranged greatly, with some participants under-dosing, but with the 
majority overdosing adrenaline boluses up to the cardiac arrest dose range, i.e. up to 20 
mcg/kg. The medical implications of these high doses have already been discussed in the 
literature review and above (scenario one).  
A potential reason for the lack of knowledge of intravenous adrenaline during 
anaphylaxis might be that in ACLS courses an intramuscular injection (IMI)  dose of 
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adrenaline is recommended, followed by an intravenous infusion of adrenaline if 
hypotension persists. This notion however, is not supported by the results of question 
four, which follows the recommendation by the ACLS guidelines for anaphylaxis. That is, 
question four asks the participant to recommend an alternate route and dose of 
adrenaline during anaphylaxis (0.5 mg IMI). This question was poorly answered, with only 
20% correctly answering. Therefore it cannot be assumed that the ACLS recommendation 
is the reason for question 3 being answered poorly as well.  
Interestingly, it was shown that there was a significant difference between those 
anaesthetists who answered question 4 correctly and had acquired an ACLS course, and 
those who had not. Of the anaesthetists who answered question 4 correctly 95% of them 
were ACLS certified. However, most of the ACLS certified anaesthetists failed the 
question. Therefore acquiring an ACLS certification made it more likely to answer 
questions about adrenaline in anaphylaxis correctly. 
Jose et al (82, 83), showed with the use of a survey, that junior doctors in medical 
institutes in the United Kingdom had knowledge deficits in resuscitation guidelines 
pertaining specifically to the use of adrenaline in anaphylaxis. Only 44.5% of junior 
doctors knew the correct dose of adrenaline in anaphylaxis, and only 16.8% would 
administer the adrenaline as per United Kingdom resuscitation council guidelines (82, 83). 
These findings were congruent with those by Gompels et al (86), who investigated the 
knowledge of senior house officers in Accident and Emergency posts in the United 
Kingdom by means of an adrenaline questionnaire relating to scenarios of anaphylaxis. It 
would appear that problems relating to the poor knowledge of doctors regarding the 
dose and route of adrenaline administration in anaphylaxis are not unique to our study. 
Clinical scenario 3 
In this scenario participants had to know the recommended starting and ceiling doses of 
an adrenaline infusion. Only 7% were able to answer both questions correctly, therefore 
passing the scenario. It was shown in question five that while 79% of the anaesthetists 
knew how to safely start an infusion, at approximately 0.05 mcg/kg/min, only 9% knew 
that the recommended safe ceiling dose is 0.5 mcg/kg/min (4, 31, 47). As shown by Table 
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4.7, question 5’s results also showed a statistically significant difference (p=0.0033) 
between answers given by anaesthetists who had completed ACLS and those who had 
not providing evidence that ACLS improved the knowledge of anaesthetists regarding 
adrenaline doses. It is of concern that question six’s most frequent answer was in fact 1 
mcg/kg/min, double the recommended dose. The implications of this are the possibility 
of myocardial ischaemia, renal failure, cerebrovascular insult, cardiac injury and death (6, 
28, 41, 43, 45). The tendency to use high adrenaline infusion doses might be explained by 
the presence of confounding literature regarding adrenaline infusions. Some literature 
suggests doses up to 1.5 mcg/kg/min, while others have not recommended a ceiling 
dose. There is simply no general consensus regarding how much adrenaline is too much 
when used as an infusion. 
The titration of drug doses is common practice with many drugs in anaesthesia, allowing 
for safer administration of drugs with particular side effects. Many junior anaesthetists 
are taught to titrate adrenaline infusions. The precaution for maximal doses is also of 
particular concern in anaesthesia, avoiding overdosing patients and causing unwanted 
side effects. It is evidenced by the questionnaire’s results that adrenaline infusions are 
generally run at higher doses than what is safely recommended. This observation is 
possibly explained by the concern in life threatening situations where higher adrenaline 
doses are a last resort. 
A defensive stance on this point is that since the teaching and general practice is to 
titrate adrenaline to its effect in critically ill patients, where adrenaline infusions are 
common, the recommended ceiling dose may not be effective. In other words, critically ill 
patients may require higher dosing of adrenaline in a scenario where a risk/benefit 
decision has been made and higher adrenaline infusion doses might be the most plausible 
treatment option. Again, this does not excuse the lack of knowledge regarding what dose 
is recommended, only that it is the result of a confusing body of evidence regarding what 
is a “safe” maximal adrenaline infusion. The American Heart Association guidelines on 
advanced cardiac life support clearly recommend that a dose range of 0.1-0.5 
mcg/kg/min be used for post cardiac arrest hypotension (4). However, it is still not 
understood why anaesthetists are not complying with recommended guidelines.  
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General 
With regard to this study’s questionnaire results, it is argued that anaesthetists’ 
knowledge is lacking, regarding adrenaline. Again, it should not be forgotten that 
knowledge is subject to fade, and thus a function of repeated knowledge update. Since 
there is no formal continued learning requirement it is not surprising that the 
anaesthetists are subject to knowledge fade. Only 69% of the sample of anaesthetists had 
completed an ACLS course, of which 26% were completed in the last two years, the 
recommendation being to update this knowledge every two years (21, 85). Therefore, 
only 18% of the sample had updated ACLS knowledge (Figure 4.2). 
Exposure to the knowledge of pharmacology in anaesthesia practice is common in 
academic institutions and may constitute being regularly updated, especially regarding 
emergency drugs. Why then, is knowledge regarding adrenaline doses so poor? 
Cabana et al. (17) discussed the attitude of the physician and how this influences the 
engagement of the learner with knowledge. This was discussed in the literature review 
and has an important impact on knowledge and learning. Studies investigating clinical 
guidelines have consistently shown that clinical practice guidelines alone have a limited 
effect on the behavioural change of the practicing physician (18-20), tying in to the fact 
that despite the ACLS guideline, anaesthetists at Wits are still making dosing decisions 
that do not comply with these guidelines. Possibly, the reasons for non-compliance are 
because anaesthetists are making clinical decisions based on their knowledge and 
experience, and are therefore justifying veering from clinical guidelines (17).  
The knowledge of anaesthetist regarding adrenaline doses in three clinical scenarios was 
found to be poor, with an overall average score of 50% for the questionnaire. Only 14% of 
anaesthetists passed the questionnaire. Interestingly, of the anaesthetists who had ever 
acquired an ACLS certification 19% passed the questionnaire. This is compared to those 
anaesthetists who had never acquired an ACLS certification, of whom only 3% passed. 
55 
 
This was statistically significant (p=0.0339). Therefore, ACLS training improves the 
knowledge of anaesthetists regarding adrenaline doses in emergencies, although the pass 
rate is still not adequate. 
To further investigate whether the more recent acquisition of knowledge was 
contributing to a better pass rate, only those anaesthetists with ACLS were compared. 
Those participants who were recently certified were compared with those who were 
certified more than two years prior.  No difference was found, implying that recently 
updating knowledge made no difference to the anaesthetists’ pass rate of the 
questionnaire. There were however, a larger proportion of anaesthetists passing if they 
had acquired the ACLS course recently, and since the groups were different in sample 
size, perhaps the sample was underpowered. 
Analysing the pass rates one scenario at a time shows repeatedly that those anaesthetists 
who were ACLS certified had more knowledge. Scenarios one and two show significant 
differences between the ACLS and no ACLS groups’ pass rates. However, in scenario three 
no difference was found. As explained before, this is probably due to there being no 
formal consensus about how much adrenaline is too much as an infusion, and thus 
anaesthetists are drawing conclusion based on clinical experience with the drug. 
In determining whether a correlation exists between the knowledge of adrenaline and 
the years of anaesthetic experience, a positive correlation was shown (r=0.2460, 
p=0.0118) indicating that anaesthetic experience improved knowledge of adrenaline in 
emergencies. Similarly, in a study carried out on Canadian anaesthesiologists, Porayko 
and Butler (87) found that anaesthesiologists with more experience scored better at 
knowledge questionnaires aimed at testing knowledge of perioperative emergencies. 
Although the correlation found in our study was weakly positive, it was limited by a short 
questionnaire that did not allow for a wider range of questionnaire results. A wider series 
of results might have improved the correlation coefficient. Furthermore, there were 
fewer anaesthetists in the categories with high numbers of anaesthetic year experience; 
this may also have limited the correlation.  
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Convincingly, when anaesthetists’ knowledge was compared across professional 
designations, a statistically significant difference between interns and consultants was 
found (p<0.01), reiterating that more experience equated to more knowledge regarding 
emergency adrenaline (87). No differences were found between the intern and registrar 
groups despite their questionnaire score medians being 33% and 50%, respectively. This 
was also the case for the registrar and consultant groups where the median scores were 
50% and 67%, respectively. This lead us to believe that the observation may have been 
underpowered as the questionnaire score medians certainly appear to be different. 
Furthermore, the groups were not matched in sample size as there was no control over 
who participated in the study. 
These result were not surprising, since gaining more knowledge with experience is logical, 
but as described by Cabana et al (17), may be restricted or hindered by adherence 
barriers as discussed in the literature, chapter 2.  
4.4 Conclusion 
The knowledge of Wits anaesthetist’s regarding the use of adrenaline in cardiac arrest, 
anaphylaxis and as an infusion is generally very poor. There is a general trend for 
knowledge to improve with more experience gained in anaesthesia, but even so, large 
knowledge deficits are still prominent. 
Generally, having previously completed an ACLS course significantly improved knowledge 
about adrenaline in emergencies. 
Interns training in anaesthesia were shown to have the least knowledge and should be 
educated regarding adrenaline use. Furthermore, the advent of ACLS is shown to be of 
significance in acquiring the necessary knowledge doctors need to treat cardiac 
emergencies and should therefore be considered as a compulsory method of education 
for junior doctors and as a refresher for doctors with more experience. 
4.5 Summary 
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The results of this study have been presented in this chapter and discussed as per the 
research objectives. The data presented include demographic data of the study 
population and responses to a questionnaire regarding professional designation, years of 
experience, ACLS accreditation, updated ACLS, and the knowledge of adrenaline in three 
clinical scenarios; cardiac arrest, anaphylaxis and as an infusion. The findings have been 
described and analysed using descriptive and inferential statistics. 
 
In the final chapter a summary, the limitations, recommendations and conclusions of the 
study are presented. 
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CHAPTER 5: Study summary, limitations, recommendations and 
conclusion 
5.1 Introduction 
In this chapter, a summary of the aim and objectives, research methods and results of the 
study will be presented. The limitations of the study will also be discussed and 
recommendations made regarding future clinical practice and research on adrenaline 
use. A conclusion will also be presented. 
5.2 Study summary 
5.2.1 Aim 
The aim of this study was to determine the knowledge of anaesthetists working in the 
Department of Anaesthesiology at Wits regarding the appropriate administration of 
adrenaline for anaphylaxis, cardiac arrest and inotropic infusions. 
5.2.2 Objectives 
The primary objectives of this study were to:  
 describe the knowledge of anaesthetists regarding adrenaline doses in three 
different clinical scenarios 
 compare whether the overall knowledge of anaesthetists, with and without ACLS 
certification, regarding adrenaline was adequate 
 compare whether the knowledge of anaesthetists, with and without ACLS 
certification, regarding each scenario was adequate 
 correlate knowledge of adrenaline with years of anaesthetic experience 
The secondary objective was to: 
 compare the knowledge of anaesthetists between different professional 
designations. 
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5.2.3 Summary of methodology 
This study was a prospective, contextual, descriptive study on a sample that consisted of 
anaesthetists working in the Wits Department of Anaesthesiology. 
In consultation with a bio-statistician a sample of 85 Wits anaesthetists was estimated. 
This was based on the assumption that 67% of anaesthetists in the Wits Department of 
Anaesthesiology would have adequate knowledge of adrenaline to an accuracy of within 
10%, and with 95% confidence. 
This study used a convenience sampling method, as is appropriate for a descriptive study 
(78). Importantly, for the purpose of this study, a sample of anaesthetists who were in 
the same place at the same time was required in order to distribute a “surprise” 
questionnaire, thus eliminating the possibility of pre-empting answers to questions. 
Therefore, anaesthetists who attended the weekly academic meeting and who were 
willing to participate in the study were included. Incomplete questionnaires returned 
were included and a score of zero was allocated to unanswered questions. Blank 
questionnaires returned were excluded. 
No questionnaires pertaining to the appropriate administration of adrenaline were 
identified in the literature. To ensure content validity the draft questionnaire was based 
on a review of the literature. To further achieve face and content validity, three 
anaesthesiologists were consulted. Following consultation minor corrections were made. 
Finally, a questionnaire was drafted to include three clinically relevant emergency 
situations whereby adrenaline would need to be used.  
Before distribution of the questionnaires, all sheets were numbered so as to keep track of 
questionnaires completed. Numbering the questionnaires also helped prevent 
reproduction of results. Furthermore, a response rate could then be calculated. 
Data was collected during February 2014 and June 2014 at departmental academic 
meetings. The researcher and two assistants were present during completion of the 
questionnaires to assist with queries and prevent data contamination. To further prevent 
data contamination, the researcher collected data at non-consecutive departmental 
meetings. 
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At the start of the meeting the researcher addressed anaesthetists, giving them a brief 
introduction to the study and inviting them to participate. Information letters and 
questionnaires were distributed allowing 10-15 minutes to complete the questionnaire. 
All the questionnaires, complete and incomplete, were placed in an unmarked envelope, 
sealed and dropped into a collection box. This helped to ensure anonymity and 
confidentiality of the anaesthetists partaking in the study. 
Based on the results of the study, an update on the appropriate use of adrenaline will be 
presented at a departmental academic meeting. 
Using Microsoft Excel 2010, data was captured onto spreadsheets. The statistical 
program, GraphPad InStat, was used to analyse data. A p-value of less than 0.05 was 
considered significant in this study. 
5.2.4 Summary of results 
104 anaesthetists responded to the self-administered questionnaire. It was found that 
large knowledge gaps exist in clinical scenarios where adrenaline is necessary. This was 
evidenced by the pass rate of the questionnaire, where only 15 (14%) anaesthetists 
managed to pass. Interestingly it was shown that anaesthetists who were ACLS certified 
had a higher pass rate than those anaesthetists who were not ACLS certified, highlighting 
the importance of attaining an ACLS certification. Updating the ACLS course however, did 
not seem to make a difference to the overall pass rate. 
With regard to the adrenaline questionnaire (Appendix 4), it was shown that questions 1-
6 were answered correctly by 86%, 48%, 60%, 20%, 79%, and 9%, respectively. This 
highlights the largest problem areas in adrenaline knowledge being with the anaphylaxis 
scenario, and with regard to maximal infusion doses of adrenaline.  
A weak positive correlation (r=0.2460) was also found between knowledge that 
anaesthetists have and the number of years spent in anaesthetic practice. This 
correlation was supported by showing that a difference exists when comparing the 
knowledge of anaesthetic interns and consultants (p<0.001). 
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5.3 Limitations 
Due to the study being contextual, it limits the generalisation of the findings to 
anaesthetic doctors, but knowledge of adrenaline in emergencies is crucial to all who 
practice medicine. 
The sample size of the study, while adequate, was not equally represented by 
anaesthetists from different professional categories. This was due to the study sample 
being a random convenience sample from the anaesthetic department meetings, thus no 
control over who was participating could be achieved.  
The sample size necessary to power the study was predicted based on the assumption 
that two thirds (67%) of anaesthetists would pass the questionnaire. Since the actual 
findings show that only 15% of anaesthetists passed, then perhaps the study was 
underpowered. 
While the questionnaire was reviewed by three anaesthesiologists before being 
distributed to the anaesthetist sample group, it is not a standard questionnaire and may 
be open to misinterpretation of the questions. If this were the case then perhaps the data 
set has a higher pass rate than what was represented by the questionnaire results. 
Many knowledge studies often have post-test lectures on the subject matter being 
investigated and then a follow up questionnaire is done two to three months later to 
determine if there was knowledge retention on the subject. This proved a difficult task in 
this study as, ethically, total anonymity was required. It would therefore not have been 
possible to pair the data set’s post-test questionnaire results, to determine whether 
there was knowledge retention.  
Considering the poor pass rate of the study questionnaire, a post-test lecture on 
adrenaline should have been given to the participants. This is an ethical dilemma that will 
still be addressed in the future. 
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5.4 Recommendations 
5.4.1 Clinical practice 
Anaesthetists at Wits should be reminded of the adrenaline guidelines in emergencies by 
means of an informative lecture. 
Wits Anaesthetist’s should ensure that they are all currently certified with an ACLS 
course. 
All ACLS certified anaesthetists could ensure that their certification is still current. 
Knowledge studies show that knowledge retention on average spans three months and 
therefore continuous updating of information is necessary. 
The American Heart Association and ACLS provide a concise and informative pocket card 
with all the relevant emergency management details on them. Drug doses and routes of 
administration can quickly and easily be accessed in the case of an emergency. 
Anaesthetists at Wits should all acquire these cards, so as to assist in the memory 
retention process, and in the state of an emergency. 
Protocol posters based on the ACLS guideline information could be put up in all theatres 
so as to make for quick referencing during emergencies. 
5.4.2 Further research 
Should the abovementioned recommendations be put into practice at Wits, further 
research should be considered in order to examine the effectiveness of such 
interventions on knowledge. 
Given that the knowledge of adrenaline among Wits anaesthetists is lacking, it is 
important to consider investigating the knowledge of other emergency scenarios that are 
pertinent to the practice of anaesthesia. 
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5.5 Conclusion 
The knowledge of anaesthetists, at Wits, regarding adrenaline use in emergencies is 
inadequate. Anaesthetists are trained to deal with life threatening cardiac emergencies 
by means of protocols that guide the proper treatment of such emergencies. Incorrectly 
dosing patients with adrenaline can lead to death by overdose or by undertreating the 
emergent condition, and may also mean untoward litigation for the anaesthetists 
responsible. 
To improve the quality of care and decrease the variation in practice, standard practice 
guidelines are endorsed by medical councils the world over. The attitudes of doctors 
towards such guidelines however, are a major contributor to decision making during 
emergencies. 
By making the anaesthetist aware of knowledge deficits and that their attitudes toward 
management protocols deters them from the recommended guidelines’ practice, then 
perhaps it is possible to improve adherence of doctors to emergency protocols. In 
conjunction with regular knowledge updates, an improvement in Wits anaesthetists’ 
management of emergencies concerning adrenaline is possible. 
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APPENDIX 3: Participants’ information sheet 
Dear Colleague, 
Hello, my name is Christopher, and I am an anaesthesiology registrar in the Wits 
Department of Anaesthesiology. 
I would like to invite you to participate in a research study titled, “Anaesthetists’ 
Knowledge of Appropriate Adrenaline Administration in Three Clinical Scenarios”. This 
study will be handed in to the Faculty Health Sciences at the University of the 
Witwatersrand in fulfilment of my MMed degree. 
This study aims to determine the current knowledge of anaesthetists at the University of 
the Witwatersrand regarding adrenaline doses and its route of administration. Doctors 
specialising in anaesthesia are expected to know the appropriate resuscitation guidelines 
regarding the use of adrenaline. In different scenario, specific doses and routes of 
administration are recommended. It is not known if anaesthetists working in the Wits 
Department of Anaesthesiology know how to appropriately administer adrenaline in an 
emergency. This will be determined by means of a self-administered questionnaire. 
Participation is voluntary and consent will be implied on completion of a questionnaire. 
All information will be confidential and anonymity maintained as no personal information 
will be required to complete a questionnaire. No penalty will be incurred for not 
participating in this study. 
All questionnaires whether complete or not, should be placed into the box supplied. 
Numbering of questionnaires is simply for practical purposes as it prevents reproduction 
of information when data capturing occurs. No numbers will identify the participant 
involved. All survey contents will only be viewed by me and my supervisors. 
The questionnaire should not take longer than 10 minutes to complete and participants 
are encouraged not to share the information provided on the questionnaire, as this gives 
an inaccurate representation of the study aims. 
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No incentives will be provided for the completion of the questionnaire. Identifying the 
current knowledge of adrenaline within the department will assist in our continued 
professional development and reduce variation in practice regarding such emergencies. 
Before completion of this survey, please ensure that you understand the above 
information. 
Your time is greatly appreciated. Any questions regarding this study can be directed to 
the following people: 
 Professor Cleaton-Jones (chairperson of the HREC): (011) 717-1234 
 Christopher Anamourlis (researcher): 073 908 5947 
Sincerely, 
Christopher Anamourlis 
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APPENDIX 4: Questionnaire 
SECTION 1: 
Please provide the following information by use of the tick box: 
Professional designation:    
Intern          
Medical Officer        
Registrar         
Career Medical Officer        
Consultant         
Years of experience in anaesthesia: < 1 Year    
     1- 5 Years    
     6-10 Years    
     11-15 Years    
     16-20 Years    
     > 20 Years    
Advanced Cardiac Life Support (ACLS):  
YES          
NO          
ACLS certified/updated in the last 2 years: 
YES          
NO          
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Scenario 1 
A healthy ASA 1 patient presents for a routine caesarean section under spinal 
anaesthesia. Ten minutes post spinal induction, cardiac arrest ensues secondary to a 
hypotensive episode. Resuscitation is initiated as per cardiac arrest algorithm using the 
Resuscitation Council of Southern Africa and American Heart Association guidelines. 
1. What is the dose of adrenaline administered under these guidelines and what is the 
recommended route of administration? 
_________________________________________________________________________
_________________________________________________________________________
_________________________________________________________________________ 
2. What is the cardiac arrest dose of adrenaline in micrograms/kilogram? 
_________________________________________________________________________ 
Scenario 2 
A healthy patient presents for a minor elective procedure requiring a general anaesthetic 
and intubation. Five minutes after the elective sequence induction, which utilised 
rocuronium as the non-depolarising muscle relaxant, the patient becomes tachycardic, 
hypotensive and you notice erythema on all limbs. She is having an acute anaphylactic 
reaction and is in anaphylactic shock. You opt to give adrenaline intravenously, as there is 
an established peripheral line. 
3. What is the recommended intravenous dose, in micrograms/kilogram? 
_________________________________________________________________________ 
4. What other doses and modes of administration do you know of, for adrenaline, as per 
recommendation by ACLS (please specify injection site)? 
_________________________________________________________________________
_________________________________________________________________________
_________________________________________________________________________ 
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Scenario 3 
The above patient responds to adrenaline boluses and the elective procedure is 
abandoned. Appropriate steroid and antihistamines are given intravenously, but despite 
this hypotension is refractory and an infusion of adrenaline through a central line is 
required. 
5. Give the minimum starting infusion dose of adrenaline, from which you will titrate, to 
treat the peripheral dilation and give inotropic support. 
_________________________________________________________________________ 
6. What is the maximum recommended infusion dose? 
_________________________________________________________________________ 
 
 
